pediatrics

pediatrics

pediatrics

A large study analyzes the benefits and risks of vegetarian and vegan diets in children

An international team has analyzed data from nearly 60 studies involving more than 48,000 children with different types of diets and compared the nutritional profile and various health parameters between those following vegan, lacto-ovo-vegetarian, and omnivorous diets. The results indicate that plant-based diets, if well-planned, can promote healthy growth with benefits such as a better cardiovascular profile and lower cholesterol levels. However, they may have difficulty achieving adequate levels of vitamins D and B12, calcium, iron, and zinc. According to the authors, the findings underscore the need for careful planning and supplementation in children following these types of diets. The study is published in Critical Reviews in Food Science and Nutrition

0

Prevalence of pediatric hypertension nearly doubled in the last 20 years

The prevalence—proportion of cases—of hypertension in minors has almost doubled worldwide between 2000 and 2020, rising from 3.4% to 6.53% in boys and slightly less in girls, according to a systematic review published in The Lancet Child & Adolescent Health. The study brings together data from nearly 444,000 children and adolescents up to the age of 19 in 21 countries.

0

The risk of myocarditis in children vaccinated against COVID-19 between in the United Kingdom was much lower than in those infected

The Pfizer-BioNTech COVID-19 vaccine has been linked to rare cases of heart inflammation in children and young people. The largest study of these risks in children, published in The Lancet Child & Adolescent Health, concluded that receiving the vaccine is associated with a risk of developing myocarditis or pericarditis within six months of 0.85 additional cases per 100,000 vaccinated children; while after COVID-19 infection, the risk is 2.24 additional cases per 100,000. The study used data from 98% of the British population under the age of 18 (almost 14 million) between January 2020 and December 2022.

 

0

Global childhood vaccination coverage increased slightly in 2024, but pre-pandemic levels were not restored

Childhood vaccination rates have increased modestly worldwide in 2024, without reaching their pre-COVID-19 pandemic levels, according to data from the WHO and UNICEF. For example, global measles vaccination coverage rose by one percentage point from the previous year, reaching 84% of girls and boys who had received one dose in 2024, compared to 86% in 2019.

0

Call to extend the use of precision oncology to minors

So-called precision oncology involves the use of drugs that target specific molecular alterations in the tumour. These therapies are usually tested in clinical trials in adults and most have not been approved for use in children. An opinion article calls for these trials to be extended to children as well, given the difficulty of conducting such trials in children due to the small number of cases. According to the authors, who publish the text in the journal Trends in Cancer, given that children and adolescents tend to tolerate therapy better than older adults, ‘the time has come to consider age-agnostic approvals, i.e. approvals that include children and adults of any age’.

0

Paediatric HIV, a major challenge on World AIDS Day

In the context of World AIDS Day, which is celebrated on 1 December, it is essential to reflect on one of the most urgent challenges in the fight against this disease: HIV in the paediatric population. A project led by the Complutense University of Madrid seeks to reduce paediatric mortality by training research leaders in sub-Saharan Africa and applying technology and innovation.

1

Babies born through assisted reproduction have increased risk of serious heart defects, study finds

The relative risk of being born with a major heart defect is 36% in babies conceived using assisted reproductive techniques, such as in vitro fertilisation, compared to newborns not using these techniques, according to a study published in the European Heart Journal. The absolute risk was 1.84% versus 1.15%. The research, which included more than seven million babies born in Denmark, Finland, Norway and Sweden, also shows that the increased risk is especially associated with multiple births, which are more common in assisted reproduction.
 

 

 

0

Slimming drug liraglutide is safe and effective in children under 12 years of age

A new study presented at the annual meeting of the European Association for the Study of Diabetes (EASD), being held in Madrid from September 9-13, and published simultaneously in the New England Journal of Medicine (NEJM), has revealed that liraglutide, an anti-obesity drug, is safe and effective in children aged 6-12 years.

0